OPTINOSE, INC.

Profile

Company Names

OPTINOSE, INC.

Addresses

1020 STONY HILL ROAD, SUITE 300, YARDLEY, PA 19067

1010 STONY HILL ROAD, SUITE 375, YARDLEY, PA 19067

1010 STONY HILL ROAD, SUITE 1010, YARDLEY, PA 19067

WFD VENTURES LLC, 152 WEST 57TH STREET, 10TH FLOOR, NEW YORK, NY 10019

Phone Numbers

267-364-3500
(212) 527-5787

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$120,431,606.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-05-10 
$4,680,000.00 
$4,680,000.00 
$0.00 
Equity 
7
2021-11-16 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
6
2020-08-18 
$250,000.00 
$250,000.00 
$0.00 
Equity 
5
2019-09-12 
$5,445,599.00 
$5,445,599.00 
$0.00 
Equity 
4
2017-03-24 
$35,000,065.00 
$35,000,065.00 
$0.00 
Equity 
3
2015-09-30 
$15,000,000.00 
$30,000,000.00 
$15,000,000.00 
Equity, Debt 
2
2014-07-22 
$34,999,943.00 
$34,999,943.00 
$0.00 
Equity 
1
2010-06-07 
$21,055,999.00 
$48,750,011.00 
$27,694,012.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HENRIK 
BRUUN 
ANDERSEN 
EXECUTIVE OFFICER
OPTINOSE, INC.
ERIC 
 
BEDNARSKI 
DIRECTOR
TARSA THERAPEUTICS, INC.   |  AMPLA PHARMACEUTICALS INC   |  SOLX INC   |  PREXA PHARMACEUTICALS INC   |  ACCUVEIN INC.   |  MVM IV LP   |  SOLX EUROPE LTD   |  BIOTHERANOSTICS, INC.   |  VERO BIOTECH INC.   |  NEUROLENS, INC.   |  MDXHEALTH SA   |  MVM VI LP   |  OPTINOSE, INC.   |  MVM J LP
VICTOR 
 
CLAVELLI 
EXECUTIVE OFFICER
OPTINOSE, INC.   |  VUMEDI, INC.
VICTOR 
M. 
CLAVELLI 
EXECUTIVE OFFICER
OPTINOSE, INC.
KLAAS 
 
DE BOER 
DIRECTOR
GENERAL FUSION INC.   |  OPTINOSE, INC.   |  SMARTKEM, INC.
KYLE 
 
DEMPSEY 
DIRECTOR
GT MEDICAL TECHNOLOGIES, INC.   |  OPTINOSE, INC.
HELENA 
KYTTARI 
DJUPESLAND 
EXECUTIVE OFFICER
OPTINOSE, INC.
PER 
 
DJUPESLAND 
EXECUTIVE OFFICER, DIRECTOR
OPTINOSE, INC.
WILLIAM 
F 
DOYLE 
DIRECTOR
VISIONSCOPE TECHNOLOGIES LLC   |  OPTINOSE, INC.
WILLIAM 
F. 
DOYLE 
DIRECTOR
IWALK, INC.   |  WFD VENTURES FUND II, L.P.   |  OPTINOSE, INC.   |  VISIONSCOPE TECHNOLOGIES LLC   |  ASPIRE BARIATRICS, LLC   |  ASPIRE BARIATRICS, INC.   |  BIOSCALE INC   |  QUALEGEN, LLC   |  INVENTURE, LLC
R. 
JOHN 
FLETCHER 
DIRECTOR
MARINA BIOTECH, INC.   |  MRI INTERVENTIONS, INC.   |  METABOLON, INC   |  OPTINOSE, INC.   |  CLEARPOINT NEURO, INC.
TOM 
 
GIBBS 
EXECUTIVE OFFICER
SOFT-TEX HOLDINGS INC.   |  OPTINOSE, INC.   |  CAREVIVE SYSTEMS, INC.
KEITH 
 
GOLDAN 
EXECUTIVE OFFICER
OPTINOSE, INC.
KEITH 
A. 
GOLDAN 
EXECUTIVE OFFICER
NUPATHE INC.   |  FIBROCELL SCIENCE, INC.   |  OPTINOSE, INC.
WILHELMUS 
 
GROENHUYSEN 
DIRECTOR
OPTINOSE, INC.
SANDRA 
L. 
HELTON 
DIRECTOR
OPTINOSE, INC.
TOMAS 
J. 
HEYMAN 
DIRECTOR
OPTINOSE, INC.
MICHELE 
 
JANIS 
EXECUTIVE OFFICER
OPTINOSE, INC.
ANTHONY 
J. 
KRICK 
EXECUTIVE OFFICER
OPTINOSE, INC.
RAMY 
 
MAHMOUD 
EXECUTIVE OFFICER
OPTINOSE, INC.
RAMY 
A. 
MAHMOUD 
EXECUTIVE OFFICER, DIRECTOR
OPTINOSE, INC.
MICHAEL 
 
MARINO 
EXECUTIVE OFFICER
EDUCATION EVOLVE, LLC   |  EELCO, LLC   |  OPTINOSE, INC.   |  AMINO, INC.   |  ACCEL ENTERTAINMENT, INC.   |  CASH FLOW CAPITAL KEY WEST LLC
MICHAEL 
F. 
MARINO 
EXECUTIVE OFFICER
NUPATHE INC.   |  FIBROCELL SCIENCE, INC.   |  OPTINOSE, INC.
PETER 
 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
GLEICHEN RESOURCES LTD.   |  OPTINOSE, INC.   |  ANCONIA RESOURCES CORP.   |  CARFINCO FINANCIAL GROUP INC.   |  SONMUNDO, INC.   |  FIRE CANNABIS INC.   |  SLANG WORLDWIDE INC.   |  CLARUS SUPER HOLDCO, LLC   |  ENGINUITY RX, INC.
PETER 
K. 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
ATTARA, LTD.   |  DUMA LIQUID OPPORTUNITIES OFFSHORE FUND LTD.   |  DUMA ALPHA FUND LTD.   |  OPTINOSE, INC.
ROBERT 
P. 
O-NEIL 
DIRECTOR
OPTINOSE, INC.
PATRICK 
 
O-NEILL 
DIRECTOR
OPTINOSE, INC.   |  CO3 VENTURES, LLC   |  EMERALD LOGIC, INC.   |  REMOTEREALITY CORP   |  GUESTLOGIX INC   |  BIOARRAY THERAPEUTICS, INC.   |  AVITUS ORTHOPAEDICS, INC.   |  SIRONA MEDICAL TECHNOLOGIES, INC.   |  MOBILE SENSE TECHNOLOGIES, INC.   |  JOULE CAPITAL, LLC   |  READYDOCK, INC.   |  SHORELINE BIOME, LLC   |  LANDSDOWNE LABS, LLC   |  ENVIRO POWER, INC.   |  LUMEDA INC.   |  CYTOVERIS INC
CATHERINE 
E. 
OWEN 
DIRECTOR
OPTINOSE, INC.
JACKSON 
 
PHILLIPS 
DIRECTOR
ANTHONY EQUITY HOLDINGS, INC.   |  OPTINOSE, INC.   |  ATAIROS STRATEGIC PARTNERS, L.P.
LARRY 
 
PICKERING 
DIRECTOR
OPTINOSE, INC.
JOSEPH 
C. 
SCODARI 
DIRECTOR
OPTINOSE, INC.
PAUL 
 
SPENCE 
EXECUTIVE OFFICER
OPTINOSE, INC.
JOSHUA 
 
TAMAROFF 
DIRECTOR
OPTINOSE, INC.   |  ACP ULYSSES HOLDINGS, INC.   |  ACP NIMBLE HOLDINGS, INC.   |  ACP MAVERICK HOLDINGS, INC.
JOSHUA 
A. 
TAMAROFF 
DIRECTOR
OPTINOSE, INC.
TERRENCE 
 
TERIFAY 
EXECUTIVE OFFICER
OPTINOSE, INC.
SRIRAM 
 
VENKATARAMAN 
DIRECTOR
OPTINOSE, INC.   |  ACP CURE ACQUISITION LLC   |  ACP NIMBLE HOLDINGS, INC.   |  NATIONAL SPINE + PAIN CENTERS HOLDINGS, LLC   |  ACP CHARGER HOLDINGS INC.   |  ACP MAVERICK HOLDINGS, INC.   |  ACP HYPERDRIVE HOLDINGS, INC.   |  ACP GOLDEN HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-05-10 
2021-11-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-16 
2020-08-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-08-18 
2019-09-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-09-12 
2017-04-07
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-24 
2015-10-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-09-30 
2015-10-13
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-22 
2014-08-04
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-22 
2010-06-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#